Rolls-Royce (LSE: RR) 2025 Close: Buybacks, Defence Momentum and SMR Tailwinds Drive Re-rating
December 22, 2025, 4:05 AM EST. Rolls-Royce Holdings plc (LSE: RR) ends 2025 with a cash-generation narrative that looks increasingly durable. Shares near 1,166p reflect a shift from a stressed turnaround to an execution-led industrial with defence exposure, civil aerospace aftermarket, and SMR tailwinds. The December catalysts are notable: a fresh interim buyback of up to £200 million (to start Jan 2, 2026) following a £1 billion programme completed in November. Buybacks reduce share count and signal management confidence in ongoing cash flows while continuing to fund the business. With full-year results due Feb 26, 2026, investors will assess how much is already priced in versus upside from defence orders and diversification of revenue.
Standard Chartered STAN 2025 Wrap: Buyback Nears $1B, Blockchain Push, and Diverging 2026 Targets
December 22, 2025, 4:00 AM EST. London – 22 December 2025. Standard Chartered (STAN) finishes 2025 with a steady stream of capital returns, a blockchain pivot, and a split on upside potential. The stock traded around 1,792p (≈ £17.92) with a market cap near £40.6bn, near the 52-week high of 1,808.5p. The standout tale is the buyback: another tranche bought and cancelled, taking cumulative spend to roughly US$996.4m and lowering the share count to about 2,265,711,794. The US$1.3bn programme runs through January 2026. Off the price-action overlay, the bank's tokenisation teams are turning "digital finance" into "boringly useful," while analysts diverge on outlook: a re-rating could still be underway, or much of the good news is already in the price. Dividend yield about 1.6%.
Standard Chartered Buyback Nears $1B, Blockchain Push, and Diverging 2026 Targets
December 22, 2025, 3:59 AM EST. Standard Chartered (STAN) closed around 1,792p on 22 December 2025, with a market cap near £40.6bn and a 52-week high near 1,808p. The focus remains the bank's evolving capital returns and digital initiatives. The bank disclosed a fresh tranche of buybacks, buying 458,902 shares at an VWAP of 1,789.47p on 19 December and planning to cancel them, underscoring a near US$1.0bn buyback so far. Cumulative spend sits around US$996.4m as the programme rolls toward a US$1.3bn cap, running through January 2026. Shares in issue would fall to about 2.2657bn after cancellation. Analysts remain split on the re-rating path: some see further upside, others consider much of the good news already in the price. The bank also pushes blockchain treasury/tokenisation efforts to turn "boringly useful."
REG – Euronext Dublin GEM Notice: Market Data Providers and Regulatory Update
December 22, 2025, 3:51 AM EST. REG – Euronext Dublin's GEM Notice highlights the data ecosystem backing the market. Market data is provided by ICE Data Services and reference data by FactSet, with copyright notes from the American Bankers Association. The CUSIP database is also supplied by FactSet. SEC filings and other documents are provided by Quartr, while TradingView contributes charting and analytics. The notice underscores the collaboration of multiple data providers that support transparency and regulatory disclosures on Euronext Dublin's GEM market.
Agnico Eagle Mines (AEM) Rises 3.3% on Strong Volume as Gold Rally Fueled by Rate-Cut Bets
December 22, 2025, 3:50 AM EST. Agnico Eagle Mines (AEM) jumped 3.3% to $174.21 on higher-than-average volume, riding a gold-price rally driven by rate-cut expectations. For the upcoming quarter, AEM is expected to earn $2.01 per share (YoY +59.5%) on $3 billion in revenue (up 35%). The consensus EPS estimate has held steady over 30 days, underscoring potential momentum unless revisions falter. AEM carries a Zacks Rank #1 (Strong Buy); peers like Barrick Mining (B) also rose. Barrick's upcoming EPS is seen at $0.86, up 87% YoY (+1.2% in the past month).
Paragon Mortgages No. 28 PLC: Cancellation Notice on 2047 VARMBS
December 22, 2025, 3:49 AM EST. Paragon Mortgages (No. 28) PLC has issued a cancellation notice affecting its Mortgage-Backed Floating Rate Notes due 15/12/2047. The notice covers multiple classes: Class D, Class C, Class Z, Class S, Class A and Class B notes, all fully paid and registered in GBP 100,000 denominations (with multiples of GBP 1,000 in excess thereof). The notes carry ISINs XS2243464174, XS2243464091, XS2243464257, XS2243464331, XS2243463879, XS2243463952, and related identifiers. This cancellation terminates the outstanding interests under the VARMBS program for the listed series. Investors should consult the issuer's official filing for terms, perform due diligence on any ongoing rights, and consider implications for valuation or future recoveries.
Carnival (CCL) Posts Record 2025 Results, Reinstates Dividend and Advances Balance-Sheet Review
December 22, 2025, 3:48 AM EST. Carnival Corporation & plc reported record full-year 2025 results, with revenue of $26.62B and net income of $2.76B, and reinstated a quarterly dividend of $0.15 per share for February 2026. It also proposed unifying its dual-listed structure into a single NYSE-listed Bermuda-incorporated company to simplify governance while strengthening its balance sheet. The narrative centers on dividend restoration and a healthier leverage profile toward an investment-grade-style target of about 3.4x by year-end 2025, supporting ship investments and potential capital returns. Risks include the remaining debt burden and bookings volatility amid geopolitical headwinds. Carnival projects $29.0B revenue and $3.7B earnings by 2028 (roughly 3.8% revenue growth; +$1.2B earnings). Fair value estimates vary, with a base around $35.76 and upside to current price; estimates range $24.61-$42.50.
Aduro Clean Technologies (CNSX:ACT) Falls 7.5% on US$20M Equity Raise; Dilution and Scale-Up Risks Rise
December 22, 2025, 3:47 AM EST. Aduro Clean Technologies has completed a US$20M public equity offering, issuing 1,739,130 common shares and 869,565 warrants to fund the construction of a demonstration-scale plant and broader corporate needs. This underlines a transition into a capital-intensive scale-up phase for its Hydrochemolytic Technology aimed at recycling and upgrading hard-to-recycle plastics. With recent share-price declines, the raise reduces near-term funding risk but increases dilution, underscoring how the story remains dependent on external capital over operating cash flow. The near-term catalyst is successful delivery and third-party validation at the demonstration scale, but financing risk persists. Three fair value estimates from the Simply Wall St Community range from US$0.23 to US$24.86 per share, highlighting divergent views on Aduro's long-term potential.
Is Virtus Investment Partners an Undervalued Opportunity After a 26% Slump in 2025?
December 22, 2025, 3:46 AM EST. Virtus Investment Partners trades around $161.54, down ~26% YTD, as active asset-manager headwinds persist. The stock still shows a potential re-rating, with a 4/6 valuation score and an Excess Returns model projecting an intrinsic value of about $208.05 per share, implying roughly 22.4% undervaluation versus the current price. The model relies on a Book Value of $136.03 and a Stable EPS of $17.48, with an implied ROE of 14.29% and a Cost of Equity of 11.92%. The analysis highlights a gap between reported profitability and investor expectations, and notes Virtus is repositioning its product lineup and capital allocation amid industry pressure and the broader shift toward low-cost passive strategies. If the company sustains excess returns, the downside risk could be limited despite the near-term weakness.
Innovative Aerosystems: Fair Value Rises to $18.83 as Retrofit Demand Supports Long-Term Growth
December 22, 2025, 3:45 AM EST. Innovative Aerosystems' fair value rose from $16.47 to $18.83, driven by structurally stronger long-term growth and a modestly lower discount rate, signaling reduced perceived risk as retrofit demand and domestic manufacturing advantages gain traction. Northland initiated coverage with an Outperform rating and a $16.50 target, highlighting the retrofit market, niche product acquisitions, and a revamped management team as catalysts for sustained growth. Bearish notes question how much of the rise is already priced in given limited coverage. The company continues to pursue aerospace and defense acquisitions with strong aftermarket potential, while balance sheet flexibility supports organic investments and M&A. A recent rebrand to Innovative Aerosystems and inclusion in the S&P Global BMI may expand liquidity and investor reach.
TAT Technologies: Margin Gains Amid a Tempered Outlook
December 22, 2025, 3:44 AM EST. Analysts peg TAT Technologies'fair value near $49 while the discount rate rises to ~9.47%, signaling a slightly higher risk backdrop. Revenue is seen advancing ~16%, keeping the long-term growth story intact despite cautious program assumptions. In the Bullish notes, Truist reiterates a Buy, pointing to EBITDA margin expansion and double-digit revenue growth, implying profits may rise as costs stay controlled. In the Bearish notes, Truist trims the target to $52 from $56, reflecting conservatism around the 131 APU and related risks. The company is pursuing inorganic growth through bolt-on deals, backed by a stronger balance sheet and new corporate development hires, with a Nov 4, 2025 vote on capital structure and governance.
DCC Plc completes £600m tender offer buyback; shares cancelled and TVR reduced; what it means for 2026 outlook
December 22, 2025, 3:43 AM EST. DCC plc completed a major £600m tender-offer buyback, cancelling 11,605,415 ordinary shares and shrinking the equity base. The offer closed on 17 December 2025 at a Strike Price of £51.70 after full subscription triggered its scaling mechanism. DCC acquired the tendered shares on-market from Davy and cancelled them, leaving post-tender Total Voting Rights at 85,423,097 ordinary shares, Total issued share capital of 87,609,229, and Treasury shares of 2,186,132. With the stock trading around £49.14 (4,914p), the premium to the strike implies investor demand to tender. The move highlights capital-return discipline and could influence per-share metrics, shaping what analysts expect for DCC's 2026 outlook.
Jupiter Wagons Stock Rallies on Promoter Stake Increase via Warrant Conversion (Dec 22, 2025)
December 22, 2025, 3:30 AM EST. Jupiter Wagons Limited (NSE: JWL; BSE: 533272) jumped in early trade after a promoter entity boosted its stake via warrant conversion. Tatravagonka A.S., part of the promoter group, acquired 28,72,340 equity shares (about 0.55%), lifting stake from 18.69% to 19.24%. Intraday gains ran about 11-13%, with Reuters noting a surge to roughly ₹294.5 on heavy volume-more than 32.9 million shares traded by late morning vs. 30-day average. The move hinges on conversion of warrants issued June 29, 2024 at ₹470 per warrant (₹10 face value + ₹460 premium). Conversion adds cash to the company and modest dilution to equity. Share count rose from 42,44,98,049 to 42,73,70,389, per Business Standard. Market chatter frames this as a promoter-led re-rating linked to warrants.
2 Top Stocks to Buy and Hold for the Long Term: Novartis (NVS) and Shopify (SHOP)
December 22, 2025, 3:29 AM EST. Long-term investing is easier in theory than in practice. The article spotlights two solid candidates: Novartis and Shopify. Novartis relies on a diversified pipeline with multiple products above $1B in sales and resilience against patent cliffs. In Q3, revenue rose 8% to $13.9B, and EPS reached $2.25. The company offers a 3% dividend yield and a 28-year dividend-growth streak, supported by launches like Fabhalta. Shopify is highlighted as having a great year, framing it as a credible long-term hold. The piece stresses that careful stock selection is crucial for turning long horizons into lasting portfolios.
REG – Fidelity Special Val: Market Data Sources & Regulatory Filings
December 22, 2025, 3:28 AM EST. This page provides Fidelity Special Val market data and reference materials. Data sources include ICE Data Services for market quotes, FactSet for reference data and CUSIP identifiers, and Quartr for SEC filings and related documents. TradingView delivers charts and price visuals. All materials reflect the 2025 copyright framework. The entry highlights how a fund table, ticker REG, is supported by these credible providers to ensure accurate pricing, holdings visibility, and regulatory documents.
ConocoPhillips Outshines Occidental Petroleum: A Closer Look at Growth Plans and Balance Sheets
December 22, 2025, 3:27 AM EST. ConocoPhillips (COP) offers a clearer growth path and a stronger balance sheet than Occidental Petroleum (OXY). Berkshire Hathaway's sizable stake in OXY underscores the stock's appeal, but Occidental's debt load from acquisitions has constrained value creation. Occidental is trying to deleverage by selling OxyChem to Berkshire for $9.7 billion, a move that helps reduce principal debt but leaves a question about a concrete, near-term plan to grow shareholder value. By contrast, ConocoPhillips has funded acquisitions with equity, preserving a fortress balance sheet, and is channeling capital into high-return projects like three LNG ventures in the U.S. and Qatar and the Willow oil project in Alaska. The result could be a clearer path to enhanced free cash flow, driven by a visible growth strategy and disciplined capital allocation compared with Occidental's debt-driven turnaround.
ERD:CA Stock Analysis with AI-Generated Signals and Trading Plans – Erdene Resource Development (Dec 22, 2025)
December 22, 2025, 3:20 AM EST. Erdene Resource Development Corporation (ERD:CA) is featured with AI-generated signals and time-stamped updates as of December 22, 2025. The report outlines conservative trading plans for the Canadian miner: a long entry near 7.30 CAD with a target of 8.55 CAD and a stop at 7.26 CAD, alongside a short setup near 8.55 CAD targeting 7.30 CAD with a stop at 8.59 CAD. The piece includes a snapshot of AI-generated ratings (Near, Mid, Long) and a formal ERD:CA Ratings for December 22. Readers are guided to check the updated signals and charts for further analysis. The data spotlight underscores the role of data-driven signals in Canadian metals names and the evolving use of AI in market timing.
ERD:CA Stock Analysis – AI Signals and Trading Plans for Erdene Resource Development
December 22, 2025, 3:19 AM EST. Erdene Resource Development Corporation (ERD:CA) is featured in today's market note, spotlighting AI-generated signals and trading plans for ERD:CA. The actionable setups include a long idea: Buy near 7.30, target 8.55, stop at 7.26; and a short idea: Sell near 8.55, target 7.30, stop at 8.59. The piece also presents ratings across Near, Mid, and Long horizons, from Weak to Strong. Readers are urged to check the timestamped data and the updated AI-generated signals for ERD:CA before trading. Included is a chart and sentiment context to support risk management and disciplined position sizing while considering the stock's Canada-listed profile.
European markets poised for a negative open as rate decisions and geopolitics weigh
December 22, 2025, 3:18 AM EST. European stocks are set for a negative open, with the FTSE 100 around -0.1%, DAX -0.17%, and CAC 40 -0.3% after last week's rally as traders digest rate decisions. The Stoxx 600 posted a fresh intraday high of 588.07 before easing. A US-UK call on Ukraine and Gaza followed, as negotiators tweaked a leaked peace proposal; a Kremlin aide cautioned it would not significantly improve prospects for peace. In France, Shein escaped a three-month ban over sex dolls; age-verification rules remain. No major data due today, though UK GDP and business investment are due after prelims. Elsewhere, Asia-Pacific markets rose after the PBOC kept rates steady, and US futures edged higher.
European stocks slide into negative open as rate decisions and geopolitics weigh on sentiment
December 22, 2025, 3:17 AM EST. European markets are poised to open lower on Monday after a strong session last week, with the FTSE 100, DAX, and CAC 40 seen about 0.1%-0.3% weaker, according to IG Group. The gains in the Stoxx 600 cooled after investors digested a flurry of rate decisions. A weekend call between the U.S. and U.K. presidents touched on Ukraine and Gaza as negotiators update a peace deal draft; critics warn the document may not yield lasting peace. In another note, Shein escaped a three-month ban in France but must apply age verification. UK GDP and business investment data are due later. Across Asia, the PBOC held its lpr steady, while US futures point to a cautious start ahead of more data.
Top Economist Warns Unemployment, Not Stock Prices, Is True Measure Of Economic Health: Tariffs Linked To Job Slump
December 22, 2025, 3:12 AM EST. Renowned economist Justin Wolfers argues that rising unemployment-not stock swings-is the clearest signal of economic health, warning that tariffs have effectively stalled job creation. He cites a hiring freeze and claims that since tariff implementation, the US has created 'close to zero jobs.' Wolfers says the next data release could show the economy shrinking and questions whether we're in a recession. He urges focusing on workers' paychecks rather than portfolio values, saying the biggest financial risk is losing your paycheck. The piece notes last week's markets: the S&P 500, Nasdaq, and Dow Jones dipped in data-heavy sessions, though the SPDR S&P 500 ETF (SPY) closed higher on Friday while QQQ rose as well. The interview was circulated on X.
Taseko Mines Announces PDMR Share Transaction by Bryce Hamming
December 22, 2025, 3:00 AM EST.Taseko Mines Limited (TSX: TKO; NYSE American: TGB; LSE: TKO) today reported a PDMR share transaction by Bryce Hamming, an executive. He exercised 15,000 share options and disposed 15,000 common shares at an average price of CAD 7.53 per share. The options carried an exercise price of CAD 1.58. The transactions were executed on December 19, 2025, and relate to Taseko ordinary shares traded on the Toronto Stock Exchange and/or NYSE American. The disclosures are in line with the EU Market Abuse Regulations. The announcement was released on December 22, 2025. For more information, visit the Taseko website or contact Investor Relations.
Augusta Gold Corp (G:CA) AI Signals & Trading Plans – Dec 22, 2025
December 22, 2025, 2:59 AM EST. AI-generated signals for Augusta Gold Corp. (G:CA) outline a concise trading plan for December 22, 2025. The setup shows a Long idea: Buy near 1.58, target 1.77, with a stop loss at 1.57; and a Short idea: Sell near 1.77, target 1.58, with a stop loss at 1.78. Ratings by term place Near and Mid at Neutral, and Long at Strong. Updated AI-Generated Signals and the chart for G:CA are available for review. The note reflects evolving sentiment and risk controls around Augusta Gold Corp., illustrating how AI-driven signals translate into clear price triggers.
Pound Cost Averaging: Drip-Feed Your Stocks & Shares ISA
December 22, 2025, 2:56 AM EST. Pound cost averaging removes market timing guesswork by investing a fixed amount regularly-often monthly-into your stocks and shares ISA. By buying more shares when prices are low and fewer when they're high, you gradually dampen the impact of volatility on your average cost without trying to time the market. For many, committing, say, £200 a month, means smoother exposure across rising and falling markets. Experts note this approach can curb the fear of investing a lump sum and can be mirrored by workplace pension contributions. Start with a low-fee provider and a simple automated plan; remember the annual ISA limit is £20,000 and adjust contributions accordingly.
Stocks to buy: Nifty outlook for the week starting December 22, 2025 – KEI Industries and JK Tyre & Industries top picks
December 22, 2025, 2:50 AM EST. SBI Securities' Sudeep Shah flags KEI Industries and JK Tyre & Industries as top stock picks for the week. Nifty showed a narrow weekly range but high volatility, closing near 25,966 with an Adam & Adam Double Bottom pattern suggesting a potential breakout above the neckline at 26,100 toward 26,300-26,500. Support sits around 25,770-25,700 near the 50-day EMA. For Bank Nifty, a Doji candle and consolidation around the 20-day EMA point to range-bound trading, with key supports at 58,600-58,700 and resistance at 59,400-59,500; a breakout beyond 59,500 could target 60,200. Traders should watch the 26,050-26,100 area on Nifty for resistance and the 58,600-59,500 zone on Bank Nifty.
Hill & Smith PLC completes on-exchange share buyback tranche: 1,753 shares acquired under £100m programme
December 22, 2025, 2:48 AM EST. On 19 December 2025 Hill & Smith PLC purchased 1,753 ordinary shares for cancellation from Deutsche Bank AG London (Deutsche Numis) as part of its £100m share buyback announced on 13 August 2025. All shares were bought as an on-exchange transaction under the LSE rules. The highest price paid was 2,185.00p, the lowest 2,155.00p, with a VWAP of 2,173.0262p. Following settlement and cancellation, the total issued shares will be 79,581,177. To date, 940,913 ordinary shares have been purchased for cancellation under the programme. The detailed trades were executed on XLON with Deutsche Bank AG as intermediary (Deutsche Numis). Enquiries: Karen Atterbury, Group Company Secretary.
Aptitude Software Group plc – 8,000 Shares Bought Under Share Buyback, Treasury Update
December 22, 2025, 2:47 AM EST. Aptitude Software Group plc (Aptitude) announces that under its Share Buyback Programme announced on 21 March 2024 it purchased 8,000 Ordinary Shares to be held in treasury. The buys were executed on 19 December 2025 on the London Stock Exchange (Main Market), at a VWAP of 288p, with a high of 290p and a low of 288p. Post-purchase, the company holds 597,319 shares in treasury and 55,610,964 shares in issue (excluding treasury). Individual trades: 5,000 at 287.50p and 3,000 at 290.00p. Canaccord Genuity Limited acted as broker. The new figures set the denominator for disclosure under the Disclosure Guidance and Transparency Rules; Aptitude says it will announce further purchases in due course.
GB Group plc: 50,000 Shares Bought Back Under Share Buyback Programme; VWAP 252.5879p
December 22, 2025, 2:46 AM EST. GB Group plc reports a tranche of its Share Buyback Programme: it purchased 50,000 Ordinary Shares at prices between 250.50p and 255.00p, with a VWAP of 252.5879p. The trades were executed through Deutsche Numis. The acquired shares will be cancelled, leaving 237,944,370 Ordinary Shares in issue and with no treasury shares; the voting rights stop at 237,944,370. This data, dated 22 December 2025, forms the denominator for disclosures under the Market Abuse Regulation and FCA Disclosure Rules. The move is part of the previously announced Share Buyback Programme originally unveiled on 23 July 2025 and extended on 25 November 2025.
LSL Property Services: 32,098 Shares Bought Back at 267.06p; Treasury and Voting Rights Update
December 22, 2025, 2:45 AM EST. LSL Property Services plc reports a purchase under its existing buyback programme. On 19 December 2025 it bought back 32,098 ordinary shares on XLON via Shore Capital Stockbrokers Limited at a price of 267.06 pence per share. The purchases form part of the share buyback programme announced 25 April 2024 and renewed 17 September 2025. The repurchased shares will be held in treasury; following the transaction the Company holds 3,324,874 shares in treasury and 101,834,076 ordinary shares in issue with voting rights (out of a total issued share capital of 105,158,950 shares). This denominator is used for notifications under the FCA's Disclosure Guidance and Transparency Rules. For further information, contact Debbie Fish, Company Secretary.
REG – IVZ II Bullet. 2027£
December 22, 2025, 2:44 AM EST. Official metadata notes for REG – IVZ II Bullet, a 2027 maturities instrument. The document cites market data from ICE Data Services and reference data from FactSet, with additional credits to FactSet for the CUSIP database and to the American Bankers Association. It also acknowledges providing SEC fillings and other documents via Quartr and sets out copyrights to TradingView, Inc. This appears to be a data/metadata snippet rather than a narrative on price action, focusing on data provenance and distribution rights for a fixed-income security. Investors should treat this as reference material and verify details in the primary offering documents before trading or pricing. Key themes: data providers, copyrights, SEC filings, fixed income metadata.
Evolving Narrative for Hanmi Financial After Target Hike and Buybacks
December 22, 2025, 2:43 AM EST. Hanmi Financial's fair value rose to $31.00 from $30.63 after a marginal revision to discount assumptions, signaling a subtly more constructive long-term narrative. Revenue growth is still seen at 12.55%, supported by healthier loan momentum and stronger management execution. The company has completed key buybacks, totaling about $16.9M for ~589k+ shares, reinforcing confidence in intrinsic value. Keefe Bruyette analyst Kelly Motta lifted the price target to $30.50 while keeping a Market Perform rating, noting beat-and-margin progress as a source of optimism but cautions that much upside may already be priced in. The evolving narrative, visible in fair value moves and forward multiples (P/E edging higher to 9.77x), warrants close tracking on watchlists or community debates.
REG – iShares II EM LatAm£: Market Data & Documentation Overview
December 22, 2025, 2:42 AM EST. REG – iShares II EM LatAm£ is presented with data from ICE Data Services for market quotes and FactSet for reference data. The page credits FactSet Research Systems Inc. for the CUSIP database, notes Quartr as the source of SEC filings and related documents, and lists TradingView for charting rights. Copyright notices from these providers underscore the data-sourcing framework behind this emerging market LatAm fund and its £ listing.
Maharashtra tops investor base, but Uttar Pradesh gains ground, NSE report shows
December 22, 2025, 2:40 AM EST. An NSE report shows Maharashtra remains the top state for registered stock market investors, with about 2.0 crore as of November 2025, but its share of the national investor pool declined to 15.9% from 19.5% in 2020. Uttar Pradesh strengthened its position, reaching 1.4 crore investors and raising its pool share from 7.7% in 2020 to 11.6% by November 2025. From Jan-Nov 2025, UP grew 15.8%, outpacing Maharashtra's 9.2%. Following them, Gujarat had around 1.1 crore, with West Bengal at 72.6 lakh and Rajasthan at 70.4 lakh; together these five states accounted for 47.7% of India's total registered investors. The NSE notes ongoing regional concentration despite new growth centers.
Revenue Up, Stock Prices Halved: 4 Growth Stocks Poised for a 2026 Rebound?
December 22, 2025, 2:38 AM EST. Despite sustained double-digit to near-50% revenue growth, select growth stocks are down 22%-55% this year, signaling a market sentiment vs. value disconnect. As the S&P 500 sits near highs, a few firms with durable moats ride powerful megatrends. Highlights include Rocket Lab USA (RKLB), whose revenue has surged while the stock sits ~20% below highs amid a first medium-lift Neutron launch; Kinsale Capital (KNSL), delivering ~39% revenue growth with best-in-class profitability yet a 24% share drop on a short-term deceleration; and MercadoLibre (MELI), leader in Latin American e-commerce/fintech facing near-term volatility but with a long runway as LATAM online penetration expands. A 2026 rebound scenario may hinge on durable earnings momentum and steady capital allocation.
ST Engineering Stock Outlook: RHB's S$9.40 Target, Record Backlog, and Dec 2025 Risks
December 22, 2025, 2:37 AM EST. ST Engineering shares traded around S$8.34 on Dec 22, 2025, as renewed broker commentary highlights a strong year-to-date rally and robust order momentum. The roughly 79% YTD gain underscores investor focus on execution across aerospace, defence, and urban mobility, as well as capital returns. RHB maintains a Buy with a target of S$9.40, pointing to TransCore momentum, electrification in public transport, and long-run capital-management plans. In 9M2025, the group reported revenue of S$9.1 billion and a record order book of S$32.6 billion, with ~S$2.8 billion of orders expected to deliver in 2025. Core risks include margins, cash conversion, and macro headlines, while December news flows emphasize mobility, defence partnerships, and satcom technology.
Keppel Ltd Stock (SGX: BN4) Dec 22, 2025: Price, Buybacks, and Monetisation Drive Re-rating
December 22, 2025, 2:35 AM EST. Keppel Ltd (SGX: BN4) traded around S$10.16-S$10.17 on Dec 22, 2025, amid a string of asset monetisation updates, ongoing share buybacks and a pipeline of listed-vehicle deals. The stock's 2025 rerating reflects investor optimism over its shift from a conglomerate to a global asset manager and operator spanning Infrastructure, Real Estate and Connectivity with higher recurring income. Highlights include: the sale of the remaining 10% and 1% stakes in Keppel DC Singapore 3 & 4 to Keppel DC REIT for S$50.5m, lifting year-to-date monetisations above S$2.4b; and a three-year extension of the PUB concession for the SingSpring Desalination Plant, boosting cash-flow visibility. Keppel also remains focused on capital recycling to fund growth and support shareholder returns.
Nasdaq Jumps 300 Points as Fear & Greed Neutral, AI Rally Leads
December 22, 2025, 2:34 AM EST. Stocks closed higher on Friday as the Nasdaq Composite added about 300 points, helped by a continued AI-focused rally. Nvidia rose 3.9%, Micron jumped over 7% after a blowout earnings print, while broader techs led gains in the S&P 500. The Dow gained roughly 183 points to 48,134.89. The S&P 500 rose 0.88% to 6,834.50, and the Nasdaq finished up 1.31% at 23,307.62. Market sentiment improved as the CNN Money Fear & Greed index sat in the Neutral zone at 45.5, up from 43.8. Investors paused ahead of December's triple witching session; existing-home sales rose 0.5% to an annualized 4.13 million in November. Sector gains were led by information technology, industrials and health care, while consumer staples and utilities lagged.
FTSE 100 Live: Gold Hits New Record as Japan Stocks Rally
December 22, 2025, 2:33 AM EST. Markets watch a risk-on session as the FTSE 100 digs higher while the gold price climbs to a fresh record. A broad move into risk assets is lifting Japanese stocks, signaling improved sentiment across Asia and Europe. Traders await upcoming data and central-bank cues that could influence global liquidity and inflation expectations. The gold rally underscores stubborn demand for bullion as a safe-haven hedge amid ongoing market jitters.
Transamerica Launches ETFs on NYSE, Expanding Its ETF Suite
December 22, 2025, 2:32 AM EST. Transamerica has begun listing its ETFs on the NYSE, expanding its asset-management footprint and giving investors quicker access to the insurer's investment strategies. The move aims to deliver cost-efficient exposure across equity and fixed-income themes with transparent pricing and daily liquidity on a major exchange. If successful, the launch could pressure peers to accelerate ETF product development and increase competition in insurer-backed funds. Traders will watch for liquidity, expense ratios, tracking error, and how the new funds fit into broader portfolios, especially for risk-managed or thematic allocations offered by the firm.
Parex Resources (TSX:PXT) Price Target Raised 11.18% to $23.21
December 22, 2025, 2:30 AM EST. Parex Resources (TSX:PXT) sees its one-year price target raised to $23.21, an 11.18% increase from $20.87. The target is an average of many estimates, with a range of $16.16 to $34.70. The new target implies a 30.90% gain from the latest close of $17.73. The stock's dividend yield stands at 8.77% and the payout ratio is 1.33, suggesting the dividend is being funded from reserves. The 3-year dividend growth rate is 0.54%. In fund flow terms, there are 84 funds holding PXT, down 10 owners quarter-over-quarter, with total institutional shares near 21.28M. Leading holders include FNKLX and IDV; overall the data reflect ongoing institutional interest in Parex Resources.
Vicarious Surgical RBOT: Price Target Slashed to $5.10, Down 44.4%
December 22, 2025, 2:29 AM EST. Vicarious Surgical (RBOT) saw its one-year price target cut to $5.10 per share, a 44.44% downgrade from the prior $9.18 target dated December 3, 2025. The target is an average of multiple analyst estimates, with current projections ranging from $5.05 to $5.25. Despite the cut, the target implies a roughly 135.02% upside from the latest close of $2.17. On the ownership side, about 52 institutions report RBOT positions, up 6.12% last quarter, with aggregate stake near 1.68 million shares (0.04% average weight, up 21.61%). Notable holders include Vk Services (15.75%), DDD Partners (3.06%), and Vanguard Total Stock Market Index Fund (1.55%). This overview comes from Fintel and includes broader fund sentiment and ownership trends.
The Trade Desk Week Ahead: Nasdaq-100 Exit, Holiday Liquidity, and Fresh Catalyst Watch for Dec. 22-26, 2025
December 22, 2025, 2:28 AM EST. TTD heads into a holiday-shortened week with two key forces: a Nasdaq-100 reconstitution that removes TTD on Dec. 22, 2025, and thin liquidity that can magnify flow-driven moves. The stock trades near the $37 level, a technical inflection where positioning and headlines can collide as markets reopen. The main catalyst is the index deletion, which can trigger passive selling and uneven flows, especially during a week with early close on Dec. 24 and a market holiday on Dec. 25. Also in focus is a small round of layoffs (~1% of staff), likely to color sentiment more than revenue. Expect heightened volatility around the rebalance window and potential pre-positioning by active managers. Monitor price action around the reconstitution window and guard against outsized moves in thin volume.
H&M Price Target Raised 11.8% to $18.24; Funds Shift Cautiously
December 22, 2025, 2:27 AM EST. Analysts raised the one-year price target for H&M Hennes & Mauritz AB (OTCPK: HMRZF) to $18.24 per share, up 11.80% from the prior $16.31 dated March 19, 2025. The target sits in a range of $12.15-$24.11 and implies a 15.73% gain versus the latest close of $15.76. Fund sentiment shows 208 funds or institutions holding HMRZF, a decrease of 8.37% this quarter, with average portfolio weight of 0.05% and total shares owned of 42,219K (down 4.38%). Top holders include VGTSX with 7,021K shares (0.50%), VTMGX with 4,379K, IEFA with 3,690K, EFA with 1,937K, and FSPSX with 1,853K. The report underscores shifting allocations rather than broad ownership changes.
OCI N.V. (OCINF) Price Target Cut 43.5% to $4.56; Analysts Signal Caution as Institutional Ownership Rises
December 22, 2025, 2:26 AM EST. Analysts trimmed OCI N.V. (OCINF) price target to $4.56 per share, a drop of 43.53% from the prior estimate of $8.07 dated November 9, 2025. The targets span $3.49-$6.15, with the average target roughly 82.5% below the latest close of $26.00. On the ownership side, 74 funds or institutions reported positions in OCINF, down slightly in the last quarter, with average portfolio weight at 0.11% and a 6.57% quarter-over-quarter rise in total shares held to 12,512K. Notable holders include Davis New York Venture Fund (NYVTX), Vanguard funds (VGTSX, VTMGX), and Avantis International Small Cap Value ETF (AVDV), each trimming allocations. The data come from Fintel; standard disclosure and investor sentiment context accompany the note.
Japan Petroleum Exploration Co. (JPTXF) Price Target Slashed 76% to $8.11
December 22, 2025, 2:24 AM EST. Japan Petroleum Exploration Co. (OTCPK:JPTXF) saw its average one-year price target slashed to $8.11, a 76.01% decline from the Feb 23, 2024 estimate of $33.78. The range now sits between $6.43 and $8.96, and the overall target is about 78.67% below the latest close of $38.00. Institutional sentiment has shifted, with 65 funds reporting positions, down slightly last quarter; average weight is 0.08% (up 31.21%), and total shares held by institutions fell to 17.14 million (-0.72%). Key holders include AVDV, VGTSX, KGGAX, and VTMGX, each trimming or reweighting exposure. The note appears on Fintel, reflecting a cautious stance on JPTXF.
Milestone Pharmaceuticals (MIST) Price Target Up 76% to $6.73 on Analyst Upgrades; Institutional Interest Rises
December 22, 2025, 2:23 AM EST. Milestone Pharmaceuticals (MIST) saw its average one-year price target raised to $6.73 per share, up 76% from the prior estimate of $3.82 dated December 3, 2025. The new target sits within a range of $2.02 to $8.40, and represents a 213.12% gain from the latest close of $2.15. On the sentiment side, 69 funds or institutions hold MIST positions, up 16 in the last quarter, with average portfolio weight at 0.30% and total institutional shares of 35,147K (up 173.87%). The put/call ratio is 0.42, signaling bullishness. Notable holders include Adage Capital Partners, Propel Bio Management, Orbimed Advisors, Simplify Asset Management, and RTW Investments, collectively adding substantial stakes. Story sourced from Fintel.
Cogna Educação S.A. Depositary Receipt (COGNY) Price Target Falls 14% to $0.69
December 22, 2025, 2:22 AM EST. Cogna Educação S.A. Depositary Receipt (COGNY) sees its average one-year price target trimmed to $0.69, a 14.02% drop from the prior $0.80 estimate dated December 5, 2025. The latest targets span $0.56-$0.84; the new target implies a 77.30% rise from the latest close of $0.39. On fund sentiment, 1 fund/institution reports positions, with the average portfolio weight at 0.00% (up 83.25%). Total institutional shares sit at 1K, down 8.35% in three months. Notably, Pnc Financial Services Group holds 1K shares (down from 2K), cutting its allocation by 83.25%. Source: Fintel.
Mesoblast MESO Price Target Increased to $20.25, Up 11.5%
December 22, 2025, 2:21 AM EST. Mesoblast Limited – Depositary Receipt (MESO) saw an updated one-year price target of $20.25 per share, up 11.48% from the prior estimate of $18.16 as of December 5, 2025. The new target range spans $19.81 to $21.21, while the latest closing price sits at $19.48, implying a 3.94% upside to the new target. On the sentiment side, 76 funds report positions in MESO, a quarterly drop of 6.17%, with the average portfolio weight at 0.03% and a 6.39% rise in total institutional shares to about 4.88 million. The put/call ratio stands at 0.07, signaling bullish interest. Major holders include QCSTRX, Legal & General Group, IBB ETF, Goldman Sachs, and Susquehanna with varying changes. Data are from Fintel.
Transcontinental (TSX:TCL.A) Price Target Increased to 28.22, Up 11.78%
December 22, 2025, 2:20 AM EST. Analysts raised Transcontinental's (TSX:TCL.A) one-year price target to $28.22, an 11.78% increase from the prior $25.24 estimate dated December 3, 2025. The target is an average of many projections, with a range of $26.26 to $30.45. The new target implies a 24.43% gain versus the latest close of $22.68. The stock yields 3.96% and carries a payout ratio of 0.39; the company has not increased its dividend in three years. Regarding ownership, 62 funds hold TCL.A, owning about 7.28 million shares (roughly 0.15% of the float), with notable activity by several funds (DISVX, VGTSX, VTMGX, DFA Canadian Small Company, EQNAX).
BlackSky Equity Warrant (BKSY.WS) Price Target Falls to $0.15
December 22, 2025, 2:19 AM EST. BlackSky Technology Inc. – Equity Warrant (BKSY.WS) sees its average 1-year price target cut to $0.15, a 23.02% drop from $0.19 (Dec 5, 2025). Targets now range $0.10-$0.25, while the target implies about a 35.12% upside from the latest close of $0.11. Fund sentiment shows 15 institutions hold positions, down 11.76% this quarter, yet total institutional shares rose 0.41% to 2.581 million. The average fund weight for BKSY.WS sits at 0.00% (up 46.54%). Notable holders include LMR Partners (1.354M), Blue Owl Capital (350K), Boussard & Gavaudan (237K), TENOR Capital (199K), and Polar Asset Management (175K); quarterly changes were flat. Source: Fintel; Nasdaq disclaimer applies.
Indian equities set to open higher on rate-cut bets as foreign inflows return
December 22, 2025, 2:18 AM EST. Indian Nifty 50 is poised to open higher on Monday after three straight weekly losses, supported by foreign inflows and expectations of further rate cuts. Gift Nifty futures (GIFc1) traded around 26,190, suggesting the Nifty 50 could extend Friday's gains above 25,966.4. Last week the index slipped 0.3% on outflow concerns and a softer rupee, but FPIs turned net buyers in the last three sessions, adding 18.31 billion rupees on Friday and 37.76 billion over the period. RBI Minutes signal room for more cuts amid moderating growth and tame inflation. Key listings to watch include Varun Beverages snapping up Twizza, Fortis Healthcare acquiring People Tree Hospital, and GE Vernova T&D India securing a HVDC contract.
REG – RNS: Key Market Data and Reference Data Providers
December 22, 2025, 2:17 AM EST. This note lists the primary market data and reference data providers behind REG – RNS disclosures: ICE Data Services delivers market data, FactSet supplies reference data and the CUSIP database, and Quartr provides SEC filings and other documents. TradingView contributes charting data and analytics, while FactSet and others hold copyright protections (© 2025). The notice underscores reliance on reputable sources for accuracy and compliance in regulatory reporting.
FAP:CA Long-Term Investment Analysis for abrdn Asia-Pacific Income Fund VCC (Canada) – AI Signals & Ratings
December 22, 2025, 2:15 AM EST. Today's update for FAP:CA analyzes abrdn Asia-Pacific Income Fund VCC using AI Generated Signals. There's no Long position offered at this time; a short near 2.89 with a stop loss 2.90 is noted. Ratings remain Neutral across Near, Mid, and Long horizons. The report emphasizes AI-driven signals and timestamped data as inputs for risk-aware decisions. With no bullish entry today, investors are advised to monitor for changes in momentum before adding exposure to FAP:CA. The takeaway: cautious stance in the Canadian market remains warranted while tracking any updates to the FAP:CA ratings and signals.
Kooth (LON:KOO) ROCE Trend Signals Reinvestment Potential and Risks
December 22, 2025, 2:14 AM EST. This piece argues that long-term stock winners often show rising ROCE alongside growing capital employed. For Kooth (LON:KOO), trailing-twelve-months to June 2025 yields an ROCE of 8.8% (EBIT £2.4m; assets £35m minus current liabilities £7.8m), in line with the industry average. After years of losses, Kooth is now profitable and reinvesting, with capital employed up about 145% as it scales. The stock, however, has fallen ~52% over five years, suggesting possible re-rating upside if fundamentals persist. The analysis flags three risks, of which one should not be ignored, and points readers to free analyst insights and valuation metrics to gauge future prospects. Overall tone: cautious optimism about reinvestment opportunities and potential upside for patient investors.
DBS Near Record Highs as Dividends, Buybacks and RMB Clearing Define 2026 Outlook
December 22, 2025, 2:13 AM EST. DBS Group Holdings closes 2025 near record territory as investors weigh growth vs capital return. As of Dec 22, 2025, the stock traded around S$55.70, flirting with a 52-week high, with a market cap near S$158B, ~14x trailing P/E and ~4.3% dividend yield. The market narrative now centers on three pillars: strong capital returns through dividends and buybacks; a growing RMB clearing role that anchors fees and cross-border flows; and a backdrop of lower-for-longer rates that compress NII and test profit outlook. DBS's strategy as an Asia hub for transaction banking and its exposure to cross-border payments and potential tokenised assets offer structural upside, even as rates remain a headwind. The 2026 debate is how much of this is priced in.
OCBC Stock Near 52-Week High as Analysts Weigh Dividends, Buybacks and 2026 Outlook (SGX: O39)
December 22, 2025, 2:12 AM EST.OCBC shares traded near the top of its 52-week range on Dec 22, 2025, up about 0.9% to S$19.73, with an intraday high of S$19.89. The stock sits at the high end of its range, viewed as a mix of income, capital return, and macro exposure. Street consensus shows 16 analysts with a Buy tilt and a 12-month target around S$19.29. In 3Q25, OCBC posted S$1.98b quarterly profit and S$5.68b nine-month profit; NIM was 1.84%, NPL 0.9%, and credit costs 16 bps. Wealth management AUM rose 18% YoY, highlighting diversification beyond net interest income. Analysts expect focus to shift from re-rating to execution on dividends, buybacks, and credit quality into 2026.
UOB Share Price Today (SGX: U11) – 2025 Outlook, 2026 Forecasts & Key Risks
December 22, 2025, 2:11 AM EST. UOB shares were around S$34.71 on Dec 22, 2025, trading in a tight range around S$34.65-34.85 as investors weigh bank headlines against a backdrop of falling rates and renewed scrutiny of China property-linked credit. In a Dec 22 interview, UOB's CEO framed the next chapter as a long-term, regional compounding story, emphasizing home-market dominance (roughly 21% of SGD deposits and 25% of SGD loans) and a growth plan to lift Southeast Asia revenue to about 30% of total by 2026, with Singapore remains ~50%. The bank targets non-interest income at 37% of revenue to offset low-rate pressure. Yet rising credit costs, asset-quality visibility, and property exposures remain the key risks; UOB previously signaled proactive provisioning in Q3 amid macro uncertainty.
Seatrium (SGX:5E2) Settlement with Maersk Offshore Wind Could Shape 2026 Outlook
December 22, 2025, 2:09 AM EST. Seatrium Limited (SGX:5E2) said it reached a settlement with Phoenix II A/S (Maersk Offshore Wind affiliate), resolving the dispute over the WTIV contract and clearing the path to delivery by Feb 28, 2026. The deal pins the US$360 million balance at delivery, of which US$250 million is funded via an interest-bearing credit extended by SGS (a Seatrium unit) and repayable over up to 10 years from vessel cash flow. SGS will secure a mortgage over the vessel and first-priority rights over the buyer's accounts. With the arbitration extinguished, the project is ~99.8% complete and management says the move should not materially affect 2025 NTAs or EPS. The relief among investors led to a positive stock reaction, and the settlement may influence the 2026 outlook and analyst targets.
Polls that kept markets talking: Reeves, IHT, and the wealth-tax debate shaping the budget
December 22, 2025, 1:58 AM EST. Across markets this year, polls on tariffs, AI and the UK budget kept readers talking. The standout study drew 4,369 votes on whether chancellor Rachel Reeves should raise taxes, cut benefits or borrow more to shore up public finances, amid rising borrowing costs and welfare reversals. Ahead of the Budget, Reeves signaled tax rises but reportedly shelved a higher income tax rate and kept thresholds frozen for two more years, aligning with Labour's manifesto. Other surveys probed tighter inheritance tax (IHT) rules and the idea of a wealth tax to ease fiscal pressure. Reeves later unveiled £26bn of tax rises, lifting the fiscal headroom to about £21.7bn per the OBR. Post-budget, 86% of respondents in our poll said Reeves had misled the public.
Inmocemento Leads European Penny Stock Spotlight as Markets Rally
December 22, 2025, 1:56 AM EST. European markets rally, with the STOXX 600 up 1.60%, highlighting opportunity in penny stocks beyond big names. Leading the charge is Inmocemento, S.A., a cement/real estate player with a €1.64B market cap. Key figures: cement revenue ~€651M and real estate €291.1M; net debt to equity 16.5%, and earnings growth 62.6% YoY, well above five-year/industry trends. The stock trades at a material discount to fair value, and short-term assets exceed liabilities, though governance concerns stem from an inexperienced board. Other screener names include Ariston Holding, Orthex Oyj, and Angler Gaming, underscoring diverse risk/reward across sectors.
ASX 200 hits over-one-month high as miners and banks lead rally
December 22, 2025, 1:55 AM EST. Australian shares rose for a third straight session, with the ASX 200 closing up 0.9% at 8,699.9, its strongest finish since November 13 and at a more than one-month high as miners led gains and gold stocks jumped about 4%. Firmer iron ore and copper prices lifted Rio Tinto, BHP and Fortescue by roughly 1%-1.7%. Financials edged higher, helped by resilience in earnings expectations, with Commonwealth Bank of Australia +0.3% and ANZ +0.7%. Analysts flagged a potential Santa Claus rally into year-end, while volumes remain thin and trading muted ahead of the minutes from the central bank's final policy meeting. Markets are pricing in a June RBA rate hike, with a ~25% chance by February.
Mid-America Apartment Communities Appears Undervalued After 12-Month Slide; DCF Signals 32.9% Discount
December 22, 2025, 1:54 AM EST. Mid-America Apartment Communities trades near $134, with a modest weekly gain but a challenging 12-month backdrop. MAA has delivered a -12% YTD and -8.8% 1-year returns, though a 5-year 27.8% rise tempers the mood as investors weigh higher rates against stable rents in Sunbelt markets. Our framework assigns a 4/6 valuation check, with a DCF implying a fair value around $200.13 and a current price about 32.9% below that level, i.e., undervalued. The analysis blends multiples and asset-based touchpoints amid resilient occupancy and measured new supply. Key risks include refinancing and development timing, but the long-term growth story may still be intact if cash flows materialize as forecast.
Top UK Dividend Stocks to Watch in December 2025
December 22, 2025, 1:53 AM EST. UK markets face global uncertainty as the FTSE 100 slides on softer demand and commodity swings, making dividend stocks a potential ballast. A screener flags high yields and resilient payouts across the UK. Standouts include Treatt (4.08%), Seplat Energy (7.59%), RS Group (3.49%), Multitude (4.00%), MONY Group (6.75%), Keller Group (3.13%), Impax Asset Management (8.25%), IG Group (3.63%), Begbies Traynor (3.86%), and 4imprint (4.58%). The selection rests on a Simply Wall St Dividend Rating framework, assessing dividend sustainability and payout coverage. Warpaint London offers ~5.7% yield but with volatility, while ICG plc yields ~4.1% with solid earnings support. As December 2025 unfolds, these picks illustrate income opportunities and potential stability in a cautious market.
Novo Nordisk: Undervalued After a 48.8% Slump? DCF Signals Big Margin of Safety
December 22, 2025, 1:52 AM EST. Novo Nordisk has fallen roughly 48.8% over the last year and 51.5% YTD as growth sentiment recalibrates amid regulatory scrutiny and competitive pressure in weight-loss and diabetes. Despite a 5/6 valuation score, the stock is argued to be undervalued based on a DCF model that pins fair value around DKK 1,060.61 per share, implying about a 70.8% gap to current prices. Analysts expect free cash flow to rise from ~DKK 67.6B (TTM) to ~DKK 199.0B by 2035 under a two-stage FCF to equity framework. The stock trades at a PE of roughly 13.27x, well below the pharmaceutical industry average and peers. The takeaway: investors face a reset in risk and growth expectations, but the setup could offer a wide margin of safety if the cash-flow trajectory proves durable.
Australian Shares Rise; Nick Scali Lifts H1 Revenue Guidance as Liontown and Origin Energy Rise
December 22, 2025, 1:50 AM EST. Australian shares closed higher, with the S&P/ASX 200 up 0.9% to 8,699.9 as gains in US tech stocks spill over on Monday. A US government review of Nvidia AI chip sales adds a geopolitical backdrop to the session. Domestically, Westpac says momentum in 2025 is driven by stronger household and business spending, with private demand and easing commodity prices supporting growth. In company news, Nick Scali (ASX:NCK) lifted its H1 revenue guidance and the stock jumped about 10%. Liontown Resources (ASX:LTR) rose 6% after open-pit mining at Kathleen Valley completed and the project transitions to underground lithium. Origin Energy (ASX:ORG) faced a Federal Court lawsuit from the AER over Centrepay payments, with shares edging higher after the decision. Markets remain choppy as the energy/commodity complex shifts.
JD Sports Fashion plc (LON:JD.) Shares Rally But Valuation Signals Potential Bargain
December 22, 2025, 1:48 AM EST. JD Sports Fashion plc (LON:JD.) has posted a roughly 16% rise on the LSE in recent months, yet remains below its yearly highs. The stock is framed as a potential bargain, with a model suggesting an intrinsic value of £1.22, above where the market is pricing the shares today. JD. carries a high beta, implying amplified moves with broader market swings. The outlook shows profit growth of about 36% over the next couple of years and higher cash flow, which could support a higher valuation. Still, much of the upside may already be priced in, and investors should weigh financial health and the management track record. For buyers, the stock could offer a buy-the-dip opportunity if market sentiment remains constructive.
Abivax (ENXTPA:ABVX) Valuation After 1,274% YTD Surge: Is the Rally Justified?
December 22, 2025, 1:45 AM EST. ABIVAX Société Anonyme (ENXTPA:ABVX) has delivered a dramatic run, up 1,274% YTD and about 44% in the last three months as investors weigh its growth prospects. Yet the stock trades at a lofty price-to-book of 15.2x, well above peers (~6.1x) and the broader French biotech group (~2.6x), suggesting the market may be pricing in more than fundamentals. A DCF fair value around €13.96 versus a €100 share price highlights the potential gap. Risks include clinical/regulatory setbacks for obefazimod and potential equity dilution to fund late-stage trials. With the stock now ahead of some targets, the key question is whether ABVX is still undervalued or overvalued by momentum, and how the market prices its next growth leg.
Entergy (ETR) valuation after strong rally: is the stock still undervalued?
December 22, 2025, 1:44 AM EST. Entergy (ETR) has outpaced utilities this year, up ~21% YTD and ~25% over the past year, though a pullback keeps the trend constructive. The core narrative ties a $40 billion capex plan over four years – expanding renewables, grid modernization and resilience – to a higher rate base and sustained above-average EPS growth, supported by a fair value around $103.61 versus a latest close near $91.50. The implied undervaluation is about 11.7% with a 22.9x P/E, above peers, signaling upside potential but with regulatory and execution risks. If the growth story holds, investors may benefit from the momentum; otherwise, valuation risk warrants careful analysis.
Australian shares hit one-month high as miners and banks lead rally
December 22, 2025, 1:37 AM EST. Australian shares rose to a one-month high as miners and banks lead a broad rally. The S&P/ASX 200 closed up 0.9% at 8,699.9, strongest since November 13, as miners surged on firmer iron ore and copper prices lifting Rio Tinto, BHP and Fortescue. Gold stocks climbed about 4% on bullion strength and bets on lower rates. Financials gained modestly, with Commonwealth Bank of Australia and ANZ posting small gains. Analysts say the traditional Santa Claus rally is in play amid thin year-end volumes. Traders await minutes from the central bank's final policy meeting for guidance, with markets pricing a June RBA hike and a small chance of one by February. The NZX 50 rose 1.3% to 13,508.3.
Robinhood and the Merry Apps: Platforms Expanding Extended Stock Trading Hours
December 22, 2025, 1:21 AM EST. From 8am-4:30pm to a global cycle across Japan to the US, this article maps how markets move billions in daily trades across 10 major exchanges and millions of transactions. It notes rising demand for extended trading hours and the rise of platforms like Robinhood that cater to it. The history runs deep: the VOC launched the world's first IPO in 1602, opening ownership to ordinary people; in 1792 the Buttonwood Tree Agreement helped seed the NYSE; Philadelphia hosted the first US exchange in 1790; and in 1971 Nasdaq ushered in electronic trading. These milestones explain how accessibility and technology reshaped investing and underpinned today's app-enabled trading era.
European Stocks Priced Below Estimated Value For Savvy Investors
December 22, 2025, 1:06 AM EST. European equities extended gains as the STOXX Europe 600 rose about 1.6%, sparking interest in stocks trading below estimated fair value. The piece highlights a broad set of undervalued names across sectors, many trading at roughly 49% discounts to estimated fair value on a cash-flow basis, including Truecaller, Sanoma, Redelfi, PVA TePla, Outokumpu, Jæren Sparebank, Inission, Dynavox, AutoStore, and Aker BioMarine. It also flags two larger caps: ACS Actividades de Construcción y Servicios, trading about 13% below a €97.66 fair value, and OHB SE, around 16.9% below €129.94, with earnings growth projections outpacing peers. The screen underscores the potential for patient investors to target cash-flow aligned valuations amid easing monetary policy and improving macro signals.
India stocks, rupee, bonds and swaps: morning snapshot at 10:00 a.m. IST
December 22, 2025, 1:00 AM EST. Equities edged higher, with Sensex up 0.5% to 85,375 and Nifty up 0.6% to 26,121, tracking tech-driven gains on Wall Street. The rupee weakened to 89.6175 per dollar (-0.4%), pressured by firmer dollar bids in the NDF market and softer regional peers. In government bonds, the 10-year note priced at 98.8825, yielding 6.6353% after a 3 bps rise amid ongoing state borrowing. Overnight index swaps showed little changed: 1Y at 5.4775%, 5Y at 5.945%. On the cash/treasury front, the call money rate sits at 5.35% and TREPS at 5.16%.
Elevra Lithium (ASX:ELV) Valuation in Focus as Momentum Lifts Lithium Sector Sentiment
December 22, 2025, 12:59 AM EST. Elevra Lithium (ASX:ELV) is gaining investor attention after a technical momentum lift amid a broader lithium rally. The stock has surged 30-day returns near 49% and 74% year to date, with a 1-year TSR around 87% despite a negative 3-year track record, signaling a momentum rebound. On valuation, Elevra trades at about 5.5x price-to-sales, well below peers (~14x) and the industry average (~122x), with a fair value estimate near 11.2x. The stock closed around A$7.31, suggesting potential upside if revenue and earnings meet forecasts while earnings remain negative. Risks include ongoing losses and execution risk at North American Lithium, where delays or cost overruns could cool sentiment. Readers can use the Screener to compare opportunities and sharpen their watchlist.
Neptune Logitek IPO debuts on BSE SME at 26% discount; muted listing
December 22, 2025, 12:58 AM EST.Neptune Logitek made a muted debut on the BSE SME, listing today at ₹100, a 26% discount to the ₹126 IPO price. The stock later slid to about ₹95.80, erasing over 5% from the listing price. Grey-market trading showed a flat GMP of +0 prior to listing. The ₹46.62 crorefixed-price issue was fully fresh, with a post-issue valuation of around ₹173 crore and subscribe 1.61x, driven mainly by retail demand. Proceeds will fund capex for expanding its asset-heavy fleet, debt repayment, and general corporate needs. Neptune Logitek is a logistics integrator offering freight forwarding, customs clearance, road/rail transport, and multimodal services, backed by GPS-enabled fleet management. FY25 revenue rose 48% to ₹260.74 crore with PAT ₹9.16 crore.
NSE reports robust FY26 fund-raising: 83 companies raise Rs 1.3 lakh crore till Nov
December 22, 2025, 12:57 AM EST. Domestic fundraising in FY26 remained robust, with 83 companies raising roughly Rs 1.3 lakh crore as of November, per an NSE report. On the mainboard, 41% of funds came from fresh equity and 59% via OFS. Fresh equity money goes to the issuer; OFS transfers existing shareholders' stakes. The newly listed firms command a combined market cap of over Rs 10 lakh crore. Retail participation rose to 25%, while QIBs' share moderated. The SME segment via Emerge saw 80 listings raising Rs 3,911 crore, with 95% via fresh equity. Regulatory measures – including a lower minimum public offering threshold, longer timelines for minimum public shareholding, easier SME migration from Emerge, and enhanced disclosure norms – underpin a resilient listing ecosystem. The report underscores sustained fundraising momentum and supportive policy tailwinds for India's capital markets.
Indian shares climb as financials and IT lead on fresh foreign inflows; rupee stabilizes
December 22, 2025, 12:52 AM EST. Indian equities climbed on Monday as financials and information technology stocks led the advance, helped by fresh foreign inflows and a firmer rupee. The Nifty 50 rose 0.61% to 26,128.4, while the Sensex gained 0.56% to 85,408.76, with all 16 sectors higher. Mid caps and small caps also advanced. FPIs bought Indian shares worth ₹18.31 billion on Friday, lifting net purchases to ₹37.76 billion over the last three sessions. Analysts say a breakout above the 26,050-26,200 band could unlock further upside. RBI minutes flagged room for rate cuts on softer growth and tame inflation. In stock-specific moves, Infosys jumped 2.3% after a US-session surge, and GE Vernova T&D India rose 8% on a HVDC contract.
India shares rally on foreign inflows as financials and IT lead gains
December 22, 2025, 12:51 AM EST. Indian equities advanced on Monday, led by financials and IT stocks as foreign investors returned to domestic equities and the rupee steadied. The Nifty 50 rose 0.61% to 26,128.4 while the BSE Sensex gained 0.56% to 85,408.76 as of 10:13 a.m. IST. All 16 sector gauges traded higher; mid- and small-caps rose about 0.4-0.5%. FPIs turned net buyers, worth ₹18.31 billion on Friday, taking their last-three-session purchases to ₹37.76 billion. Analysts flagged a potential year-end rally if rupee reverses and FPI flows sustain, with the Nifty needing a break above 26,050-26,200 for convincing upside. Infosys jumped 2.3%; GE Vernova T&D India climbed 8% on a HVDC contract.
Organigram Global (TSX: OGI) 2025 Results and 2026 Revenue Guidance Above CAD 300 Million
December 22, 2025, 12:50 AM EST. Organigram Global (TSX: OGI) reported FY2025 results: CAD 403.02 million in sales, CAD 259.18 million in revenue, and a CAD 24.76 million net loss (CAD 0.194 per share). For fiscal 2026, the company guided net revenue above CAD 300 million with margin expansion driven by rising domestic and international demand, better cultivation, streamlined logistics, and an improved product mix. Investors will weigh whether improved scale can convert into sustainable profitability as the incoming CEO from British American Tobacco leads U.S. product rollouts. Risks include execution risk in cultivation, logistics, and product mix, plus valuation questions as fair-value estimates span from CA$3 to CA$21.46. The setup offers upside potential but also near-term pressure amid a long, weak return profile.
Financials and IT Stocks Lead Indian Shares Higher on Foreign Inflows
December 22, 2025, 12:49 AM EST. Indian shares rose as financials and IT stocks led gains, buoyed by renewed foreign inflows and a firmer rupee. The Nifty 50 climbed 0.61% to 26,128.4 and the Sensex added 0.56% to 85,408.76 as of 10:13 a.m. IST, with all 16 sectors higher. Broad-based gains extended to mid and small caps. FPIs bought ₹18.31 billion on Friday, lifting three-session purchases to ₹37.76 billion. Analysts see potential for a year-end rally if the rupee stabilizes and FPI flows persist. Minutes from the RBI meeting hint at room for rate cuts amid slower growth and softer inflation. Infosys rose 2.3% after a US session surge; GE Vernova T&D India jumped 8% on an HVDC contract.
NSE report: Domestic market fund-raising stays strong; 83 companies raise ₹1.3 lakh crore till Nov FY26
December 22, 2025, 12:48 AM EST. Domestic fundraising in FY26 remained robust, with 83 companies raising ₹1.3 lakh crore on the NSE's mainboard as of November. The mix skewed toward fresh equity (41%) and OFS (59%), lifting the market capitalisation of the newly listed group to over ₹10 lakh crore. Retail participation rose to 25%, while QIBs' share moderated. The NSE also highlighted strength in the SME segment via the Emerge platform, with 80 listings raising about ₹3,911 crore; around 95% of this came from fresh equity. Regulatory actions, including lowering the minimum public offering threshold, extending timelines for minimum public shareholding, smoother SME migration to the mainboard, and enhanced disclosures, underpin continued listing activity and long-term market growth.
NSE: Domestic stock market fund raising stays robust in FY26 as 83 companies raise Rs 1.3 lakh crore till Nov
December 22, 2025, 12:44 AM EST. Fund mobilisation in the domestic market stayed robust in FY26, with 83 companies raising Rs 1.3 lakh crore as of November, per an NSE report. On the mainboard, fresh equity accounted for 41% and OFS for 59%, underscoring a mix of new capital and exits by early investors. The overall listed universe now commands a market capitalisation exceeding Rs 10 lakh crore, reflecting the depth of recent IPOs. Retail participation rose to about 25%, even as QIB share moderated. The SME segment on the Emerge platform saw 80 listings raising Rs 3,911 crore, with 95% via fresh equity. Regulatory measures-lowering minimum public offering requirements, extending thresholds for minimum public shareholding, easing SME migrations, and enhancing disclosures-have reinforced the listing ecosystem and long-term growth.
Alphabet (GOOGL) Valuation: Is It Undervalued After 3-Month and 1-Year Gains?
December 22, 2025, 12:43 AM EST. Alphabet (GOOGL) shares have surged ~22% in 3 months and ~58% in the last year, raising questions about current valuation. The analysis credits strong execution across Search, YouTube, and especially Cloud, with gains suggesting momentum after a multi-year TSR. With double-digit revenue and profit growth, Alphabet trades just below some analyst targets, fueling debate whether it remains undervalued or has priced in the next growth leg. A narrative fair value of $340 implies modest mispricing, supported by a fortress-like balance sheet: cash/marketables >$120B, negligible debt, operating margin ~25-30%, and free cash flow of $70-$80B/year. Risks include regulatory pressure and AI-driven search disruption that could erode Alphabet's moat. Valuation shows a PE ~29.8 vs 16.8 for peers and a fair multiple ~37.3.
Alphabet (GOOGL) Valuation in Focus After 3-Month and 1-Year Rally
December 22, 2025, 12:42 AM EST. Alphabet's stock has surged ~22% in 3 months and ~58% in a year, prompting a valuation-check amid strong execution in Search, YouTube, and Cloud. A narrative-based fair value of $340 suggests Alphabet is undervalued vs. the latest close of $307.16. The fortress-like balance sheet-cash & marketable securities over $120B, minimal debt-supports an operating margin around 25-30% and free cash flow of $70-$80B annually. Yet regulatory pressure and AI-driven disruption could compress the moat and re-rate risk. At roughly 29.8x earnings vs. 16.8x for the sector, and a potential fair multiple near 37.3x, investors weigh growth quality against premium valuations. Read the full narrative and valuation breakdown.
Alphabet (GOOGL) Valuation In Focus After 3-Month and 1-Year Stock Gains
December 22, 2025, 12:41 AM EST. Alphabet (GOOGL) has climbed about 22% in three months and more than 58% in the last year, raising questions about its valuation. The latest narrative pegs a Fair Value of $340-slightly above the current close-implying the stock is undervalued at that level. The bulls point to momentum from solid execution in search, YouTube, and cloud, supported by a fortress-like balance sheet: cash and marketable securities topping $120B, negligible debt, and an operating margin of ~25-30%, with FCF of $70-80B annually. Yet risks-regulatory pressure and AI-driven search disruption-could compress Alphabet's moat and re-rate valuation. At roughly 29.8x earnings vs. the 16.8x industry, the stock looks rich if the market's future growth and quality expectations fade. A fresh breakdown tests the upside versus risk.
Organigram Global (TSX: OGI) 2025 results and 2026 revenue guidance above CAD 300M: implications for investors
December 22, 2025, 12:40 AM EST. Organigram Global Inc. reported FY2025 results: sales CAD 403.02m, revenue CAD 259.18m, net loss CAD 24.76m (EPS CAD -0.194). Despite the loss, management guided FY2026 net revenue above CAD 300m with expected margin expansion driven by stronger domestic and international demand, better cultivation, leaner logistics, and an improved product mix. Investors will watch whether the new CEO from British American Tobacco can translate scale into sustainable profitability as Organigram expands US hemp-derived products. The execution risk rises around cultivation, logistics, and product mix, especially after a strong run in the stock and a historically weak multi-year track record. Valuation views vary: Simply Wall St's four fair-value estimates span CA$3 to CA$21.46, highlighting divergent investor opinions on the stock's fair value versus the ambitious 2026 goal.
Organigram Global (TSX:OGI) Eyes CAD 300M+ 2026 Revenue Amid 2025 Loss; Growth vs. Execution Risk
December 22, 2025, 12:37 AM EST. Organigram Global Inc. posted its full-year 2025 results with CAD 403.02 million in sales, CAD 259.18 million in revenue, and a CAD 24.76 million net loss (EPS -0.194). For 2026, it guided net revenue above CAD 300 million and signaled margin expansion driven by rising domestic and international demand, better cultivation, streamlined logistics, and a more favorable product mix. The narrative hinges on turning scale into sustainable profitability while navigating Canadian cannabis and U.S. hemp markets, aided by an incoming CEO from British American Tobacco and ongoing U.S. product rollouts. Risks include execution risk around cultivation, logistics, and mix changes. With mixed fair-value views and a recent share surge, the stock presents a balance of opportunity and near-term pressure for investors.
Marex Group (MRX) Valuation After 20% One-Month Surge: Is the Upside Durable?
December 22, 2025, 12:36 AM EST. MRX stock has gained ~20% in the past month, trading around $39.19 as investors reassess growth and risk in Marex Group's diversified trading, clearing, and risk-management model. The rally comes after a solid 90-day run and a 1-year total return of ~28%, yet the shares still trade below a key analyst target, pointing to potential upside if the growth trajectory and margins hold. A fair value around $47.70 suggests undervalued status, driven by technology investments, productivity gains, and operating leverage. However, risks include possible hiccups in acquisitions, regulatory lawsuits, and whether the market has already priced in cash flows, as the SWS DCF fair value lands nearer $38.73, below the current price. Investors should weigh growth prospects, earnings power, and risk factors before sizing exposure.
Marex Group MRX Valuation After 20% One-Month Surge: Is the Upside Real?
December 22, 2025, 12:35 AM EST. Marex Group (MRX) has surged about 20% over the last month, trading near $39.19 after a steady 90-day gain and a 1-year return of 28.2%. The rally comes as traders embrace its diversified model-trading, clearing, and risk management-and as technology investments boost desk productivity and margins. Our read: a valuation case that tilts toward upside if growth and execution hold, with a narrative fair value around $47.70 suggesting the stock remains undervalued versus broader targets. Yet a counterview-SWS DCF pegs fair value near $38.73-signals potential vulnerability if cash flows don't materialize. Key risks include acquisitions hurdles and securities lawsuits that could dent earnings quality and confidence. Overall, the setup favors upside but with meaningful risks to monitor.
Marex Group MRX Valuation Revisited After 20% One-Month Surge
December 22, 2025, 12:34 AM EST. Marex Group (MRX) delivered a ~20% one-month gain, lifting the stock to around $39.19 as investors weigh its diversified trading, clearing, and risk-management model. The 90-day gain and a 1-year total shareholder return of ~28.2% underscore momentum as growth catalysts-technology investments and scalable platforms-support desk productivity, revenues per employee, and operating leverage. At last close, fair value references center around ~$47.70 (narrative fair value), implying the equity looks undervalued versus targets, while the SWS DCF model pegs ~$38.73, suggesting a smaller margin of safety if cash flows are already priced in. Key risks include acquisitions missteps and securities lawsuits denting earnings quality and client confidence. The upside rests on improving margins and higher earnings power if growth remains intact.
REG – RNS: Market Data & Reference Data Providers Credited
December 22, 2025, 12:17 AM EST. REG – RNS lists the providers underpinning market data and reference information: ICE Data Services supplies market data, FactSet delivers reference data and the CUSIP database, with copyright notices from FactSet Research Systems Inc. and the American Bankers Association. The notice also credits Quartr for SEC filings and other documents and TradingView, Inc. for related materials. All rights reserved for 2025. The disclosure highlights how data providers and distributors collaborate to power market research, trading workflows, and regulatory reporting.
Sensex, Nifty Open in Green as Global Cues Turn Positive
December 22, 2025, 12:16 AM EST. Sensex rises about 507 points to 84,436 and Nifty up about 165 to 26,132 as the market opens in the green on Monday, snapping last week's decline amid positive global cues. Broad-market indices also gain, with midcap and smallcap up around 0.5-0.6%. Top gainers in the Nifty pack include Hindalco, Tech Mahindra, and TCS, while Asian Paints, Bajaj Finance, Max Healthcare, and Cipla lag. Sectoral strength comes from metal, IT, and media. Analysts flag a possible year-end rally supported by the rupee reversal and FIIs' cash-market buying, which could fuel short-covering and lift benchmarks. Global peers posted gains as China held its loan-prime rates, and Asia-Pacific markets advanced on Monday.
With $500 to Invest: 3 Cryptocurrencies to Buy and Hold for Decades
December 22, 2025, 12:02 AM EST. With markets volatile and regulation evolving, the piece argues cryptocurrencies are in their infancy and adoption is still expanding. It urges investors to focus on established tokens with real-world use cases and to start small-around $500. The picks include XRP from the XRP Ledger and Ripplenet, which aim to speed and reduce costs for cross-border payments and may gain traction as an alternative to SWIFT. It also highlights Bitcoin as digital gold-the largest crypto by market cap with anti-inflationary properties and growing corporate and potential U.S. reserve interest. The message is clear: buy into durable fundamentals, and hold for the long term while acknowledging crypto risk.
Nifty50 above 26,100; Sensex up 450+ points as year-end rally looms
December 22, 2025, 12:01 AM EST. Nifty50 rose to 26,121.75 and the Sensex climbed to 85,401.92 in early trade, up about 0.6% each. This is the start of a short year-end week. Geojit's Dr. VK Vijayakumar says a year-end rally could gain traction on a sharper rupee reversal and FIIs turning buyers, with a favorable earnings setup supporting the move. Still, high valuations may cap gains. Globally, tech-led US stocks and firmer oil prices underpinned risk appetite. FPIs bought Rs 1,830 crore and DIIs Rs 5,723 crore. Investors will watch earnings and macro cues as the festive week unfolds.
